STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
GRANT INCOME AND OTHER	$ 113,728	$ 35,000	$ 144,133	$ 146,567
OPERATING EXPENSES:
Research and development (9 months excluding R&D depreciation of $208,750 and $338,350, respectively, included below and 3 months excluding R&D depreciation of $47,931 and $109,867, respectively, included below)	3,769,538	2,469,166	9,208,900	7,519,586
Depreciation and amortization	79,008	109,718	302,871	391,571
General & administrative	1,778,381	1,669,214	5,428,897	5,154,141
Total operating expenses	5,626,927	4,248,098	14,940,668	13,065,298
OPERATING LOSS	(5,513,199)	(4,213,098)	(14,796,535)	(12,918,731)
GAIN ON DERIVATIVE INSTRUMENTS	1,079,392	3,390,389	7,363,854	142,532
INTEREST INCOME	29,027	28,665	89,394	86,393
INTEREST EXPENSE	(42,693)	(41,402)	(127,803)	(220,812)
NET LOSS	(4,447,473)	(835,446)	(7,471,090)	(12,910,618)
ISSUANCE OF ADDITIONAL SHARES DUE TO RESET PROVISIONS			0	(250,000)
MODIFICATION OF WARRANTS	(59,531)	0	(59,531)	(325,620)
INDUCEMENT WARRANTS			0	(1,593,000)
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (4,507,004)	$ (835,446)	$ (7,530,621)	$ (15,079,238)
NET LOSS PER COMMON SHARE
BASIC	$ (0.01)	$ 0.00	$ (0.03)	$ (0.06)
DILUTED	$ (0.02)	$ (0.02)	$ (0.05)	$ (0.06)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	309,306,502	258,467,582	300,383,239	244,738,972
DILUTED	309,306,502	258,467,582	300,383,239	244,738,972